1Y Annualised Return
▲64.46%
3Y Annualised Return
▲45.24%
5Y Annualised Return
▲44.47%
|
|
|
Fortis Healthcare Limited was incorporated on February 28, 1996, by the Singh brothers as an extension of their pharmaceutical legacy. The company is headquartered at the Fortis Memorial Research Institute in Gurgaon, with its registered office in Mohali, Punjab. It operates 36 healthcare facilities across India, Dubai, and Sri Lanka, offering a range of medical services. Fortis is listed on both the Bombay Stock Exchange (BSE: 532843) and the National Stock Exchange (NSE: FORTISEQ), and is backed by Malaysia’s IHH Healthcare.
Fortis Healthcare operates through three primary segments: hospitals, diagnostics, and pharmacies. The hospital division provides multi-specialty tertiary and quaternary care services including cardiology, oncology, orthopaedics, neurology, and more. The diagnostics arm, Agilus Diagnostics, offers pathology and imaging services through a broad network. Its pharmacy business supports the hospital ecosystem and generates additional retail revenue. The company earns primarily through inpatient and outpatient services, diagnostics, pharmacy sales, and day-care procedures. Medical tourism contributes to the revenue as international patients seek cost-effective, high-quality treatment across Fortis facilities.
As of 10 Jul, 2025, Fortis Healthcare share price is ₹773.4. The stock opened at ₹785 and had closed at ₹784.7 the previous day. During today’s trading session, Fortis Healthcare share price moved between ₹766.55 and ₹785.80, with an average price for the day of ₹776.17. Over the last 52 weeks, the stock has recorded a low of ₹456.55 and a high of ₹813.00. In terms of performance, Fortis Healthcare share price has increased by 12.6% over the past six months and has increased by 64.46% over the last year.
Over the past
Market Cap (in crs)
58,392.24
Face Value
10
Turnover (in lacs)
12,758.72
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
2007.2 Cr | 1928.26 Cr | 1988.39 Cr | 1858.9 Cr | 1785.88 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
7849.69 Cr | 6931.17 Cr | 6359.35 Cr | 5744.95 Cr | 4076.68 Cr | 4684.96 Cr |
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
183.38 Cr | 252.24 Cr | 188.85 Cr | 173.39 Cr | 198.82 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
797.86 Cr | 635.71 Cr | 611.15 Cr | 765.8 Cr | -103.73 Cr | 79.32 Cr |
Fortis Healthcare Ltd reported a 7.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.
Its expenses for the quarter were down by 9.7% QoQ and - - YoY.
The net profit decreased 20.1% QoQ and - - YoY.
The earnings per share (EPS) of Fortis Healthcare Ltd stood at 2.4 during Q4FY25.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 844224 Rs | 1682043 Rs |
Week Rs | 615369 Rs | 1195412 Rs |
Month Rs | 969594 Rs | 1628690 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,05,811.13 | 6001 | 7635 | 7,469.00 | -2.57% | 6.23% | 4.58% | 15.18% | 87.10% | 0.38% | 81.62 | 49.49 | 12.11 | ||
40,261.12 | 1171 | 2370.2 | 1,969.20 | -2.05% | 7.34% | 50.14% | 59.56% | 208.82% | 0.23% | 93.39 | 49.49 | 18.42 | ||
602.35 | 31,082.08 | 315.5 | 675 | 610.00 | -5.25% | 5.02% | 18.91% | 76.83% | 212.94% | 19.77% | 5.28 | 49.49 | 7.52 | |
1,21,673.90 | 836.6 | 1314.3 | 1,247.40 | -3.59% | 5.43% | 8.84% | 39.48% | 241.78% | 0.12% | 161.07 | 49.49 | 14.68 | ||
712.00 | 28,565.92 | 412 | 715.7 | 708.35 | 4.06% | 6.34% | 9.88% | 65.01% | 198.04% | 0.00% | 96.85 | 49.49 | 13.17 | |
34,964.71 | 935.5 | 1328.8 | 1,278.70 | 9.97% | 8.86% | 21.37% | 4.41% | 0.00% | 0.04% | 70.14 | 49.49 | 10.00 |
Fortis Healthcare share price is ₹771.55 in NSE and ₹772 in BSE as on 10/7/2025.
Fortis Healthcare share price in the past 1-year return was 64.45. The Fortis Healthcare share hit a 1-year low of Rs. 456.55 and a 1-year high of Rs. 813.
The market cap of Fortis Healthcare is Rs. 58392.24 Cr. as of 10/7/2025.
The PE ratios of Fortis Healthcare is 454.88 as of 10/7/2025.
The PB ratios of Fortis Healthcare is 6.43 as of 10/7/2025
The Mutual Fund Shareholding in Fortis Healthcare was 25.77% at the end of 10/7/2025.
You can easily buy Fortis Healthcare shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Fortis Healthcare share price is ₹813 and ₹456.55 as of 10/7/2025.
Please be aware that Fortis Healthcare stock prices are subject to continuous fluctuations due to various factors.